Mark Dybul

Mark Dybul is a declared insider of Lir Life Sciences Corp., with filings sourced from SEDI. The record holds 4 filings, for trades running from 4 June 2026 to 8 October 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 9 October 2026 came the latest disclosure, a transaction in Lir Life Sciences Corp. Typically, a trade is published a median of 1 day after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.